Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress.
Ketola K; Hilvo M; Hyötyläinen T; Vuoristo A; Ruskeepää AL; Orešič M; Kallioniemi O; Iljin K; British Journal Of Cancer, 2012, vol. 106, issue 1, p 99, ISSN 15321827. ISBN 15321827.
Full Text Resources Located for this Citation